COMMUNIQUÉS West-GlobeNewswire

Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome

11/10/2018 - 23:04

CHESTERBROOK, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), today announced the outcome of the meeting of the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products [...]

Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access

11/10/2018 - 22:36

Global resolution secures patient access to Sandoz biosimilar Hyrimoz ® (adalimumab)[1] for the reference medicine Humira ® ** Resolution paves way for 2018 launch in key European markets and secures US market entry [...]

Align Technology Expands Invisalign Interactive Brand Experience Pilot Program to Connect More Consumers With Invisalign Doctors

11/10/2018 - 22:21

8 New Invisalign Experience Locations in Q4 to Connect Consumers with Invisalign Doctors Designed to Address 300+ Million Consumer Market for Clear Aligner Orthodontics Invisalign Experience Pilot Locations Show [...]

Integra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018

11/10/2018 - 22:05

PLAINSBORO, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2018 financial results on Wednesday, [...]

KemPharm Provides Highlights from KOL Investor Event Focused on the ADHD Treatment Landscape

11/10/2018 - 22:05

Event Held Today, October 11, 2018 CORALVILLE, Iowa, Oct. 11, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, [...]

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

11/10/2018 - 22:05

SAN CARLOS, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating [...]

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares

11/10/2018 - 22:03

Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization of Corium’s Corplex Donepezil MENLO PARK, [...]

Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Company’s Clinical Program

11/10/2018 - 22:01

—FDA acknowledged acceptability of a single-arm cohort for registration in metastatic melanoma post PD-1 blocking antibody and, if BRAF mutation positive, a BRAF inhibitor or BRAF inhibitor with MEK inhibitor —FDA [...]

Progenics Advances 1095, PSMA-Targeted Therapeutic Candidate for the Treatment of Metastatic Prostate Cancer, into Phase 2 Clinical Development Following Discussions with the FDA

11/10/2018 - 22:01

– Trial will utilize PyL imaging in order to target the patients most likely to benefit, advancing the Company’s theranostic approach to the treatment of prostate cancer – NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- [...]

Tetraphase Pharmaceuticals Announces Commercial Launch of XERAVA™ in the United States

11/10/2018 - 22:01

FDA-Approved for the Treatment of Complicated Intra-Abdominal Infections Provides Broad Spectrum of Coverage Against Gram-negative, Gram-positive, and Anaerobic Bacteria for a Range of Patients with Empiric and [...]

Immune Design Announces Program Updates & Portfolio Prioritization for G100 and CMB305

11/10/2018 - 22:01

G100 development to accelerate in follicular lymphoma and beyond CMB305 to be deprioritized to support focus on G100 Cash runway extended into 2021 Conference call at 2:00 pm Pacific today SEATTLE and SOUTH SAN [...]

Chimerix to Host Annual Investor Update on October 17, 2018

11/10/2018 - 22:01

DURHAM, N.C., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that it will host the Company's annual [...]

NSS Labs Announces 2018 Breach Detection Systems Group Test Results

11/10/2018 - 21:52

Three Products Receive Recommended Rating; Two Products Miss at Least One Evasion AUSTIN, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based [...]

CFN Media Enhances its LA Studio for Exclusive Interviews and CFN Weekly Show

11/10/2018 - 21:40

Seattle, WA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]

CV Sciences, Inc. to be a Featured Panelist at TheStreet’s Investing Event on October 13th in New York, NY

11/10/2018 - 21:07

LAS VEGAS, Oct. 11, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc . (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our,” “us” or “we”), preeminent supplier and manufacturer of phytocannabinoids including industry-leading [...]

Eckert & Ziegler BEBIG SA and Eckert & Ziegler Strahlen- und Medizintechnik AG will propose to their shareholders the merger of the two companies

11/10/2018 - 19:31

Press release Inside and regulated information 11 October 2018, 19:30 (CEST) Eckert & Ziegler BEBIG SA and Eckert & Ziegler Strahlen- und Medizintechnik AG will propose to their shareholders the merger of the [...]

Eckert & Ziegler BEBIG SA et Eckert & Ziegler Strahlen- und Medizintechnik AG vont proposer à leurs actionnaires la fusion entre les deux sociétés

11/10/2018 - 19:31

Communiqué de presse Information privilégiée et réglementée 11 Octobre 2018, 19:30 (CEST) Eckert & Ziegler BEBIG SA et Eckert & Ziegler Strahlen- und Medizintechnik AG vont proposer à leurs actionnaires la [...]

Texas Companies and Universities Bring World’s Largest Algae Technology Conference to The Woodlands

11/10/2018 - 19:08

Event showcases breakthrough algae innovations in human health, agriculture, wastewater and fuel HOUSTON, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Texas-based companies and universities are working with the Algae Biomass [...]

CTD Holdings to Host Webinar on its Phase I Clinical Trial for Niemann-Pick Disease Type C

11/10/2018 - 18:57

ALACHUA, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced a one- [...]